The incidence and body site of skin cancers in the population groups of South Africa
Article first published online: 19 FEB 2014
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Photodermatology, Photoimmunology & Photomedicine
Volume 30, Issue 5, pages 262–265, October 2014
How to Cite
Norval, M., Kellett, P. and Wright, C. Y. (2014), The incidence and body site of skin cancers in the population groups of South Africa. Photodermatology, Photoimmunology & Photomedicine, 30: 262–265. doi: 10.1111/phpp.12106
Conflicts of interest:
- Issue published online: 16 SEP 2014
- Article first published online: 19 FEB 2014
- Accepted manuscript online: 14 JAN 2014 02:58AM EST
- Manuscript Accepted: 20 DEC 2013
- basal cell carcinoma;
- cutaneous melanoma;
- South Africa;
- squamous cell carcinoma of the skin
Data regarding basal cell carcinoma (BCC), squamous cell carcinoma of the skin (SSCC) and cutaneous melanoma (CM) in multiracial populations are sparse. Here the incidence and body site of these tumours in the South African population in 2000–2004 were analysed.
Annual age-standardized incidences and body sites of BCC, SSCC and CM in black, coloured, Asian and white groups were obtained from histological confirmed cases, reported to the National Cancer Registry.
Highest annual incidences of BCC, SSCC and CM occurred in the white group, followed by coloured, then Asian and then black. BCCs and SSCCs were about twice as common in males than females. CM was the least frequent skin tumour, and BCC the most frequent, except in black people. The head was the commonest body site for SSCC and BCC in all groups and both sexes, whereas the lower limb was the predominant site for CM in black people. Mean age at diagnosis was generally mid-50s for CM, and mid-60s for BCC and SSCC.
In South Africa, differences in reported incidence rates and body sites of skin tumours by population group and sex occur. Host characteristics, particularly skin phototype, and personal behaviour are likely to affect the risk of these cancers.